STOCK TITAN

Director Paul K. Wotton sells 10,000 Vericel (VCEL) shares around $33

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Vericel Corp director Paul K. Wotton sold 10,000 shares of Common Stock in open-market transactions. On May 11, 2026, he reported selling 7,500 shares at $32.64 per share and 2,500 shares at $33.05 per share. These are discretionary, open-market sales of existing shares.

Positive

  • None.

Negative

  • None.
Insider Wotton Paul K
Role null
Sold 10,000 shs ($327K)
Type Security Shares Price Value
Sale Common Stock 2,500 $33.05 $83K
Sale Common Stock 7,500 $32.64 $245K
Holdings After Transaction: Common Stock — 26,302 shares (Direct, null)
Footnotes (1)
Shares sold (first trade) 7,500 shares Common Stock sold at $32.64 on May 11, 2026
Price per share (first trade) $32.64/share Open-market sale of Vericel Common Stock
Shares sold (second trade) 2,500 shares Common Stock sold at $33.05 on May 11, 2026
Price per share (second trade) $33.05/share Open-market sale of Vericel Common Stock
Total shares sold 10,000 shares Aggregate of two open-market sales by director
Common Stock financial
"security_title: "Common Stock" for both reported transactions"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
open-market sale financial
"transaction_action: "open-market sale" for each Form 4 entry"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
transaction code "S" financial
"transaction_code_description: "Sale in open market or private transaction""
non-derivative financial
"transaction_type: "non-derivative" for each Common Stock sale"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wotton Paul K

(Last)(First)(Middle)
C/O VERICEL CORPORATION
64 SIDNEY STREET

(Street)
CAMBRIDGE MASSACHUSETTS 02139

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vericel Corp [ VCEL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/11/2026S2,500D$33.0526,302D
Common Stock05/11/2026S7,500D$32.6418,802D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Sean Flynn, as Attorney-in-Fact for Paul Wotton05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Vericel (VCEL) report for Paul K. Wotton?

Vericel reported that director Paul K. Wotton sold 10,000 shares of Common Stock. The Form 4 shows two open-market sale transactions totaling 10,000 shares on May 11, 2026, at prices in the low-$30 range.

How many Vericel (VCEL) shares did Paul K. Wotton sell and at what prices?

Paul K. Wotton sold a total of 10,000 Vericel shares. He sold 7,500 shares at $32.64 per share and 2,500 shares at $33.05 per share, according to the Form 4 insider filing.

What type of transactions did Vericel (VCEL) director Paul K. Wotton execute?

The filing shows Paul K. Wotton executed open-market sale transactions. Both entries use transaction code “S,” described as a sale in open market or private transaction, and are classified as non-derivative Common Stock sales.

When did the Vericel (VCEL) insider sales by Paul K. Wotton occur?

The reported insider sales took place on May 11, 2026. On that date, Paul K. Wotton completed two separate open-market sales of Vericel Common Stock, as detailed in the Form 4 transaction table.

Does the Vericel (VCEL) Form 4 show any option exercises for Paul K. Wotton?

The Form 4 does not report any option exercises for Paul K. Wotton. All listed entries are non-derivative Common Stock sales, and the derivative transaction summary indicates zero derivative exercises or derivative transactions.

Is Paul K. Wotton a director or officer of Vericel (VCEL) in this filing?

In this Form 4, Paul K. Wotton is identified as a director of Vericel Corp. The reporting-person data marks him as a director, with no officer role or ten-percent-owner status indicated in the submission.